Skip to main content

Table 4 Summary of Androgen deficiency in the aging male (ADAM) scoring by visit and treatment

From: A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency

Visit

Observed value

Change from baseline

Intervention

(VISPO)

n = 33

Comparator

(SPO)

n = 33

Placebo

n = 33

p-value**

Intervention

(VISPO)

n = 33

p-value*

Comparator

(SPO)

n = 33

p-value*

Placebo

n = 33

p-value*

p-value**

Visit 1

4.33 ± 1.67

4.15 ± 1.68

4.30 ± 1.76

0.898(1)

 

Visit 2

3.97 ± 1.74

4.12 ± 1.69

4.48 ± 1.73

0.461(1)

−0.36 ± 0.70a

0.005

−0.03 ± 0.53ab

0.744

0.18 ± 0.68b

0.136

0.007(2)

Visit 3

3.73 ± 1.74

4.21 ± 1.43

4.45 ± 1.64

0.179(1)

−0.61 ± 1.06a

0.002

0.06 ± 0.90b

0.701

0.15 ± 0.94b

0.361

0.003(1)

  1. Data are presented as Mean ± SD; n = No of subjects
  2. a-b values within a row with different superscript letters differ (p < 0.05), as analysed by one-way ANOVA
  3. *p values were compared within each group from baseline using paired t test
  4. **p values were compared between groups
  5. 1)P values were derived from ANOVA, and Scheffe test was used to post hoc test
  6. 2)P values were derived from Kruskal-Wallis test, and Dunnett T3 test was used to post hoc test
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us